[1]Manns MP, Czaja AJ, Gorham JD, et al.Diagnosis and management of autoimmune hepatitis[J].Hepatology, 2010, 51 (6) :2193-2213.
|
[2]Teufel A, Galle PR, Kanzler S.Update on autoimmune hepatitis[J].World J Gastroenterol, 2009, 15 (9) :1035-1041.
|
[3]Umemura T, Zen Y, Hamano H, et al.IgG4 associated autoimune hepatitis:a differential diagnosis for classical autoimmune hepatitis[J].Gut, 2007, 56 (10) :1471-1472.
|
[4]Czaja AJ.Current concepts in autoimmune hepatitis[J].Ann Hepatol, 2005, 4 (1) :6-24.
|
[5]Czaja AJ.Autoimmune liver disease[J].Curr Opin Gastroenterol, 2007, 23 (3) :255-262.
|
[6]Oo YH, Hubscher SG, Adams DH.Autoimmune hepatitis:new paradigms in the pathogenesis, diagnosis, and management[J].Hepatol Int, 2010, 4 (2) :475-493.J Clini Hepatol, June 2011, Vol.27, No.6
|
[7]Longhi MS, Ma Y, Meili-Vergani G, et al.Adaptive immunity in autoimmune hepatitis[J].Dig Dis, 2010, 28 (1) :63-69.
|
[8]Ishak KG.Pathologic features of chronic hepatitis.A review and update[J].Am J Clinical Pathol, 2000, 113 (1) :40-55.
|
[9]Iwai M, Jo M, Ishii M, et al.Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis[J].Hepatol Res, 2008, 38 (8) :784-789.
|
[10]Lefkowitch JH.Chronic hepatitis in Scheuer's Liver biopsy interpretation[M].8th.USA:Elesvier, 2010:133-161.
|
[11]Zen Y, Notsumat K, Tanaka N, et al.Hepatic centrilobular zonal necrosis with positive antinuclear antibody:a unique subtype or early disease of autoimmune hepatitis[J].Hum Pathol, 2007, 38 (11) :1669-1675.
|
[12]Misdraji J, Thiim M, Graeme-Cook FM, et al.Autoimmune hepatitis with Centrilobular necrosis[J].Am J Surg Pathol, 2004, 28 (4) :471-478.
|
[13]Odze RD, Goldblum JR.Surgical pathology of the GI tract, liver, biliary tract and pancreas 2nd[M].Philadelphia, PA:Saunders Elesvier, 2009:1035-1043.
|
[14]Burt AD, Portmann BC, Ferrell LD.McsWeen's Pathology of the liver 5th[M].Philadelphia, PA:Churchill livingstone Elsevir, 2007:493-515.
|
[15]Umemura T, Zen Y, Hamano H, et al.Immunoglobin G4-hepatopathy:association of immunglobin G4-bearing Plasma cells in liver with autoimmune pancreatitis[J].Hepatology, 2007, 46 (2) :463-471.
|
[16]Chung H, Watanabe T, Kudo M, et al.Identification and characterization of IgG4-associated autoimmune hepatitis[J].Liver Int, 2010, 30 (2) :222-231.
|
[17]Umemura T, Zen Y, Hamano H, et al.Clinical significance of immunoglobulin G4-associated autoimmune hepatitis[J].J Gastroenterol, 2011, 46 (Suppl 1) :48-55.
|
[18]Mieli-Vergani G, Vergani D.De novo autoimmune hepatitis[J].J Hepatol, 2004, 40 (1) :3-7.
|
[19]Kerkar N, HadzicN, Davies ET, et al.De-novo autoimmune hepatitis after liver transplantation[J].Lancet, 1998, 351 (9100) :409-413.
|
[20]Berardis, Lodato F, Gramenzi A, et al.High incidence of allograft dysfunction i liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence:possible de novo autoimmune hepatitis[J].Gut, 2007, 56 (2) :237-242.
|
[21]Zhang Y, Wang B, Wang T.De novo autoimmune hepatitis with centrilobular necrosis following liver transplantion for primary biliary cirrhosis:a case report[J].Transplant Proc, 2010, 42 (9) :3854-3857.
|
[22]Fiel MI, Agarwal K, Stanca C, et al.Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus[J].Liver Transpl, 2008, 14 (6) :861-871.
|
[23]Demetris AJ, Sebagh M.Plasma cell hepatitis in liver allografts:variant of rejection or autoimmune hepatitis[J].Liver Transpl, 2008, 14 (6) :750-755.
|